481 related articles for article (PubMed ID: 31477625)
1. CD8
Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
3. Discrepant Clinical Significance of CD28
Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
5. Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.
Pal S; Dey D; Chakraborty BC; Nandi M; Khatun M; Banerjee S; Santra A; Ghosh R; Ahammed SM; Chowdhury A; Datta S
Hepatology; 2022 Sep; 76(3):759-774. PubMed ID: 35000202
[TBL] [Abstract][Full Text] [Related]
6. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
7. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
[TBL] [Abstract][Full Text] [Related]
8. CXCR5
Jiang H; Li L; Han J; Sun Z; Rong Y; Jin Y
DNA Cell Biol; 2017 Apr; 36(4):321-327. PubMed ID: 28157399
[TBL] [Abstract][Full Text] [Related]
9. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
[TBL] [Abstract][Full Text] [Related]
10. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
12. Changes of costimulatory molecule CD28 on circulating CD8+ T cells correlate with disease pathogenesis of chronic hepatitis B.
Li X; Kong H; Tian L; Zhu Q; Wang Y; Dong Y; Ni Q; Chen Y
Biomed Res Int; 2014; 2014():423181. PubMed ID: 25013781
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
15. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B.
Wang Y; Bai J; Li F; Wang H; Fu X; Zhao T; Xu W; Zhang J; Ni B; Wu Y
Immunol Invest; 2009; 38(5):434-46. PubMed ID: 19811419
[TBL] [Abstract][Full Text] [Related]
17. HBV-specific CD8 T cells present higher TNF-α expression but lower cytotoxicity in hepatocellular carcinoma.
Zhao L; Jin Y; Yang C; Li C
Clin Exp Immunol; 2020 Sep; 201(3):289-296. PubMed ID: 32474905
[TBL] [Abstract][Full Text] [Related]
18. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
Front Immunol; 2021; 12():649197. PubMed ID: 34234772
[TBL] [Abstract][Full Text] [Related]
19. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
Gu Y; Lian Y; Gu L; Chen L; Li X; Zhou L; Huang Y; Wang J; Huang Y
BMC Infect Dis; 2019 Mar; 19(1):216. PubMed ID: 30832595
[TBL] [Abstract][Full Text] [Related]
20. Decrease of CD69 levels on TCR Vα7.2
Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
